您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2014, Vol. 52 ›› Issue (10): 49-54.doi: 10.6040/j.issn.1671-7554.0.2014.279

• 临床医学 • 上一篇    下一篇

原发性高血压患者血清IMD、CysC、FGF23与动脉粥样硬化的关系

李静, 徐彤彤, 余帆   

  1. 桂林医学院附属医院特需病区, 广西 桂林 541001
  • 收稿日期:2014-04-29 修回日期:2014-06-23 出版日期:2014-10-10 发布日期:2014-10-10
  • 通讯作者: 徐彤彤。E-mal：xutongtongguilin@163.com E-mail:xutongtongguilin@163.com
  • 基金资助:
    广西壮族自治区自然科学基金（2012GXNSFAA502001）；桂林市科学研究与技术开发计划课题（20130120-1）；广西医疗卫生适宜技术研究与开发课题（S201316-03）

Correlation of serum IMD, CysC and FGF23 with atherosclerosis in essential hypertensive

LI Jing, XU Tongtong, YU Fan   

  1. Department of Cardiology, Affiliated Hospital of Guilin Medical College, Guilin 541001, Guangxi, China
  • Received:2014-04-29 Revised:2014-06-23 Online:2014-10-10 Published:2014-10-10

PDF (PC)

191

摘要： 目的 探讨联合检测血清中叶素（IMD）、胱抑素C（CysC）、成纤维细胞生长因子23（FGF23）与原发性高血压（EH）患者动脉粥样硬化（AS）的关系。方法 选择EH患者60例（EH组）及健康体检者60例（对照组），应用高分辨二维超声技术测量颈动脉内膜中层厚度（cIMT）评估AS程度，采用酶联免疫吸附法（ELISA）测血清IMD、CysC及FGF23水平，同时检测相关生化指标。结果 ①EH组cIMT及血清IMD、CysC、FGF23水平高于对照组 （P<0.05）；②不同级别高血压患者cIMT及血清IMD、CysC、FGF23水平随血压分级升高而递增 （P<0.05）；③以cIMT为依据将患者分为cIMT正常组、cIMT增厚组及斑块形成组，血清IMD、CysC、FGF23水平随cIMT增厚而升高，3组患者血清IMD、CysC、FGF23水平比较，差异有统计学意义（P<0.001）；④cIMT与IMD、CysC、FGF23呈正相关（r=0.770、0.616、0.822，P<0.001），进一步行非条件Logistic回归分析显示，收缩压（SBP）、IMD、CysC、FGF23、高密度脂蛋白（HDL）是cIMT增厚的独立危险因素（OR=1.104、1.120、1.107、1.069、3.592，P<0.05）。结论 血清IMD、CysC及FGF23水平与血压分级和cIMT密切相关，是cIMT增厚的独立危险因素，三者可能参与了EH的发生发展，并影响AS的进程。联合检测EH患者血清IMD、CysC及FGF23水平可在一定程度上反映AS情况，为AS的防治提供新思路。

关键词: 中叶素, 成纤维细胞生长因子23, 动脉粥样硬化, 高血压, 胱抑素C

Abstract: Objective To analyze the association between serum intermedin (IMD), Cystatin C (CysC) and fibroblast growth factor 23 (FGF23) with atherosclerosis (AS) in essential hypertensive (EH). Methods Serum IMD, CysC and FGF23 levels of 60 patients with EH (EH group) and 60 healthy subjects (control group) were detected with enzyme-linked immunosorbent assay (ELISA). The carotid intima media thickness (cIMT) was measured with UCG. Results The cIMT, serum IMD, CysC and FGF23 levels were significantly higher in EH group than in control group (P<0.05). In EH patients, cIMT, serum IMD, CysC and FGF23 levels increased with elevated blood pressure levels (P<0.05). Based on the level of cIMT, all subjects were divided into normal cIMT group, thickened cIMT group and mottling formation group. The serum IMD, CysC and FGF23 levels in the three groups rose with cIMT, and the difference had statistical significance (P<0.001). The cIMT level was positively correlated with serum IMD, CysC and FGF23 levels (r=0.770, 0.616, 0.822; P<0.001). When cIMT level was taken as the dependent variable, unconditioned Logistic regression analysis showed that SBP, IMD, CysC, FGF23, and HDL were independent risk factors forcIMT (OR=1.104, 1.120, 1.107, 1.069, 3.592; P<0.05). Conclusion Serum IMD, CysC and FGF23 levels are closely associated with blood pressure classification and cIMT, indicating that they are independent risk factors of cIMT. They may participate in the pathogenesis of EH and affect the process of AS. Combined-detection of serum IMD, CysC and FGF23 can reflect the severity of AS and provide a new approach for its prevention and treatment.

Key words: Intermedin, Fibroblast growth factor 23, Hypertension, Cystatin C, Atherosclerosis

中图分类号: 

  • R544.11
[1] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志, 2011, 19(8):701-743. The rebision committee for China's prevention and cure guide of hypertension. Hypertension Prevention and Cure Guideline of China 2010[J]. Chinese Journal of Hypertension, 2011, 19(8):701-743.
[2] Stein J H, Korcarz C E, Post W S, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk:summary and discussion of the American society of echocardiography consensus statement[J]. Prev Cardiol, 2009, 12(1):34-38.
[3] Stein J H, Korcarz C E, Hurst R T, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk:a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force[J]. J Am Soc Echocardiogr, 2008, 21(2):93-111.
[4] Sibal L, Agarwal S C, Home P D. Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes[J]. Diabetes Metab Syndr Obes, 2011, 19(4):23-34.
[5] Roh J, Chang C L, Bhalla A, et al. Intermedin is a calcitonin/calcitonin generelated peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes[J]. J Biol Chem, 2004, 279(8):7264-7274.
[6] Pan C S, Yang J H, Cai D Y, et al. Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2[J]. Peptides, 2005, 26(9):1640-1646.
[7] Fujisawa Y, Nagai Y, Miyatake A, et al. Effects of adrenomedullin 2 on regional hemodynamics in conscious rats[J]. Eur J Pharmacol, 2007, 558(1-3):128-132.
[8] Anastasi A, Brown M A, Kembhavi A A, et al. Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum[J]. Biochem J, 1983, 211(1):129-138.
[9] Kestenbaum B, Rudser K D, de Boer I H, et al. Differences in kidney function and incident hypertension:the multiethnic study of atherosclerosis[J]. Ann Intern Med, 2008, 148(7):501-508.
[10] 刘亚普, 张新梅, 王美玲, 等. 高血压患者外周血胱抑素C水平的检测[J]. 国际检验医学杂志, 2013, 34(4):468-469. LIU Yapu, ZHANG Xinmei, WANG Meiling, et al. The detection of peripheral blood cystatin C level in hypertensive[J]. International Journal of Laboratory Medicine, 2013, 34(1):468-469.
[11] Luc G, Bard J M, Lesueur C, et al. Plasma cystatin-C and development of coronary heart disease:The PRIME Study[J]. Atherosclerosis, 2006, 185(2):375-380.
[12] Choe J Y, Park S H, Kim S K. Serum cystatin C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment[J]. J Korean Med Sci, 2010, 25(1):42-48.
[13] 黄冠华, 孙刚, 闫旭龙. 胱抑素C、颈动脉内膜中层厚度与冠心病的关系[J]. 临床心血管病杂志, 2013, 29(7):547-548. HUANG Guanhua, SUN Gang, YAN Xulong. The relationship between CystatinC, carotid intima media thickness and coronary heart disease[J]. J Clin Cardiol, 2013, 29(7):547-548.
[14] Komaba H, Fukagawa M. FGF23-parathyroid interaction:implications in chronic kidney disease[J]. Kidney Int, 2010, 77(4):292-298.
[15] Yilmaz M I, Sonmez A, Saglam M, et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease[J]. Kidney Int, 2010, 78(7):679-685.
[16] Sigala F, Savvari P, Liontos M, et al. Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-kappaB pathway[J]. J Cell Mol Med, 2010, 14(9):2273-2280.
[1] 吴逸南 葛志明 李方 贺红 姜虹 张运. 自发性高血压大鼠肾脏血管紧张素转换酶2的表达[J]. 山东大学学报(医学版), 2209, 47(6): 5-.
[2] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31.
[3] 尹妮,杨关林,姜钧文,王春田,王凤耀,贾连群,高晓宇,潘嘉祥,李芹,李佳,冯元洁,高玉竹,周鹤,张哲. 巴马小型猪冠状动脉粥样硬化模型的评价方法[J]. 山东大学学报（医学版）, 2017, 55(7): 1-5.
[4] 于涛,刘焕乐,冯新,徐付印,陈亚飞,薛付忠,张成琪. 基于健康管理队列的高血压风险预测模型[J]. 山东大学学报（医学版）, 2017, 55(6): 61-65.
[5] 严芳英,单晓兰,李静媛,张杰,闫雪芳,杨奕,卜培莉. 吡格列酮通过调控Sirt3改善高血压引起的心肌纤维化机制[J]. 山东大学学报（医学版）, 2017, 55(5): 13-18.
[6] 李睿,马伟红,任满意,赵萌萌,姜珊,巨媛媛,郭颖,孙昭辉,隋树建. TWEAK与原发性高血压患者心脏重塑的相关性[J]. 山东大学学报（医学版）, 2017, 55(5): 49-55.
[7] 王维军,周宁全,王超. CT定位微创徒手穿刺软通道技术治疗中等量高血压脑出血68例[J]. 山东大学学报（医学版）, 2017, 55(5): 61-65.
[8] 张华,庄霞,刘振东,刁玉涛,杜佳晨,崔谊. 磁共振弥散张量成像技术评价高血压对年轻成年人脑白质损伤[J]. 山东大学学报（医学版）, 2017, 55(5): 56-60.
[9] 张云华,李杰. 颈动脉斑块内新生血管显影程度及血浆Lp-PLA2水平对急性脑梗死的临床诊断价值[J]. 山东大学学报（医学版）, 2017, 55(3): 112-116.
[10] 魏丹丹,张澄. 血管紧张素Ⅳ型受体过表达对早期动脉粥样硬化斑块形成的影响[J]. 山东大学学报（医学版）, 2016, 54(8): 1-5.
[11] 王丹,亓恒涛,孙书珍. 原发性肾病综合征儿童颈动脉结构和功能改变[J]. 山东大学学报（医学版）, 2016, 54(5): 88-91.
[12] 孙鹏飞,孟晓,张凯,黎莉. 抵抗素样分子 β在动脉粥样硬化斑块稳定性中的作用[J]. 山东大学学报（医学版）, 2016, 54(3): 1-4.
[13] 王立轩,张璐,许新,李思雪,刘敏,王亚萍,马慧娟. 慢性间歇性低压低氧通过PI3K依赖的eNOS活化增强大鼠胸主动脉舒张[J]. 山东大学学报（医学版）, 2016, 54(2): 11-15.
[14] 李雪丽,徐丽君. 以孤立性眩晕为首发症状的双侧对称性桥臂梗死1例[J]. 山东大学学报（医学版）, 2016, 54(12): 90-92.
[15] 王小飞, 王成伟, 王志刚, 丁璇, 王敏卿. 应用Enterprise支架治疗动脉粥样硬化性椎-基底动脉狭窄的探讨[J]. 山东大学学报（医学版）, 2015, 53(8): 44-48.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发